Metropolitan Life Insurance Company (MetLife)’s Arrowhead Research ARWR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,101
| Closed | -$174K | – | 179 |
|
|
2024
Q1 | $174K | Buy |
6,101
+194
| +3% | +$6.21K | 0.01% | 774 |
|
|
2023
Q4 | $181K | Hold |
5,907
| – | – | 0.01% | 777 |
|
|
2023
Q3 | $159K | Buy |
5,907
+197
| +3% | +$6.04K | 0.01% | 783 |
|
|
2023
Q2 | $204K | Hold |
5,710
| – | – | 0.01% | 671 |
|
|
2023
Q1 | $145K | Sell |
5,710
-647
| -10% | -$20.4K | 0.01% | 803 |
|
|
2022
Q4 | $258K | Hold |
6,357
| – | – | 0.01% | 613 |
|
|
2022
Q3 | $210K | Hold |
6,357
| – | – | 0.01% | 661 |
|
|
2022
Q2 | $224K | Hold |
6,357
| – | – | 0.01% | 658 |
|
|
2022
Q1 | $292K | Sell |
6,357
-36,050
| -85% | -$1.78M | 0.01% | 657 |
|
|
2021
Q4 | $2.81M | Sell |
42,407
-1,093
| -3% | -$75.1K | 0.04% | 386 |
|
|
2021
Q3 | $2.72M | Sell |
43,500
-1,463
| -3% | -$94.7K | 0.04% | 372 |
|
|
2021
Q2 | $3.72M | Buy |
44,963
+695
| +2% | +$51.7K | 0.05% | 287 |
|
|
2021
Q1 | $2.94M | Buy |
44,268
+166
| +0.4% | +$12.9K | 0.04% | 358 |
|
|
2020
Q4 | $3.38M | Sell |
44,102
-1,385
| -3% | -$88.6K | 0.05% | 303 |
|
|
2020
Q3 | $1.96M | Sell |
45,487
-2,205
| -5% | -$95.2K | 0.03% | 421 |
|
|
2020
Q2 | $2.06M | Sell |
47,692
-6,572
| -12% | -$232K | 0.04% | 392 |
|
|
2020
Q1 | $1.56M | Buy |
54,264
+86
| +0.2% | +$3.47K | 0.03% | 481 |
|
|
2019
Q4 | $3.44M | Buy |
54,178
+23,809
| +78% | +$1.18M | 0.05% | 302 |
|
|
2019
Q3 | $856K | Buy |
30,369
+1,154
| +4% | +$34.2K | 0.01% | 946 |
|
|
2019
Q2 | $774K | Buy |
29,215
+288
| +1% | +$6.32K | 0.01% | 1042 |
|
|
2019
Q1 | $531K | Hold |
28,927
| – | – | 0.01% | 1257 |
|
|
2018
Q4 | $359K | Hold |
28,927
| – | – | 0.01% | 1426 |
|
|
2018
Q3 | $555K | Hold |
28,927
| – | – | 0.01% | 1285 |
|
|
2018
Q2 | $393K | Buy |
+28,927
| New | +$270K | 0.01% | 1483 |
|
|
2016
Q4 | – | Sell |
-36,692
| Closed | -$270K | – | 2632 |
|
|
2016
Q3 | $270K | Sell |
36,692
-3,610
| -9% | -$23.4K | ﹤0.01% | 2137 |
|
|
2016
Q2 | $214K | Hold |
40,302
| – | – | ﹤0.01% | 2274 |
|
|
2016
Q1 | $194K | Hold |
40,302
| – | – | ﹤0.01% | 2194 |
|
|
2015
Q4 | $248K | Hold |
40,302
| – | – | ﹤0.01% | 2089 |
|
|
2015
Q3 | $232K | Buy |
40,302
+1,127
| +3% | +$7.09K | ﹤0.01% | 2181 |
|
|
2015
Q2 | $280K | Buy |
+39,175
| New | +$269K | ﹤0.01% | 2166 |
|
|
2015
Q1 | – | Sell |
-40,657
| Closed | -$300K | – | 2229 |
|
|
2014
Q4 | $300K | Hold |
40,657
| – | – | ﹤0.01% | 2122 |
|
|
2014
Q3 | $601K | Hold |
40,657
| – | – | ﹤0.01% | 1602 |
|
|
2014
Q2 | $582K | Buy |
+40,657
| New | +$533K | ﹤0.01% | 1727 |
|
Other funds holding ARWR
ACA
SPC
AG
Metropolitan Life Insurance Company (MetLife)'s ARWR Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Arrowhead Research (ARWR) in Q2 2024, closing a stake of 6,101 shares — an estimated $174K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ARWR in Q2 2014 and held it in 33 quarters. The position peaked at $3.72M in Q2 2021. 272 funds tracked by Wall St. Rank hold ARWR as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Arrowhead Research position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 6,101 Arrowhead Research shares in Q2 2024, an estimated $174K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Arrowhead Research in Q2 2014 and held it in 33 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Arrowhead Research position peaked at $3.72M in Q2 2021.
- 272 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.